X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home IPR Data Management

Big Data Steering Group To Better Data Effectiveness, Search

Content Team by Content Team
3rd August 2022
in IPR Data Management, News
Big Data Steering Group To Better Data Effectiveness, Search

A third workplan with measures due by 2025 has been released by the joint Big Data Steering Group of the European Medicines Agency (EMA) as well as the Heads of Medicines Agencies (HMA).

The new strategy, according to EMA, will improve the integrated approach of data analysis into the regulatory assessment of pharmaceuticals. The agency issued a statement in which it declared that using revolutionary technology and the evidence generated by big data would enhance public health by expediting drug development, enhancing treatment outcomes, and easing early patient access to novel treatments.

The HMA/EMA Big Data Steering Group evaluates its workplan every year to include any newly emerging areas of interest. The group was established in May 2020 to provide guidance to both the EMA and HMA on the execution of the ten priority recommendations identified by the Big Data Task Force. The new strategy principally focuses on initiatives connected to medications for humans while adhering to the primary recommendations of the previous Big Data Task Force.

The work plan details deadlines and deliverables, including:

  • By 2025, the EMA’s network of data and services in Europe will have more than 100 studies each year, which will allow for a better use of real-world evidence for evaluating medications.
  • By the end of 2022, the EU regulatory network will have a data quality framework that is based on analysis and discussions about data quality with a variety of stakeholders, including patients, healthcare workers, regulators, the pharmaceutical industry, and academics.
  • Release of a public European real-world data catalogue and a good practise manual on real-world metadata to improve data discoverability. The creation of analytics tools and uniform clinical trial methods will also improve the ability to search for information in regulatory documents.
  • Under the heading of “EU network skills,” the provision of training in biostatistics, pharmacoepidemiology, and data science for policymakers with specialised access for patients, medical professionals, and academics.

Big data are very big, fast-growing datasets that are collected using a variety of settings and equipment, such as wearable technology and electronic health information. The EMA and HMA suggest that big data, when combined with rapidly advancing technology, can supplement the substantiation from clinical trials by filling in knowledge gaps about a medicine and aiding in a better understanding of diseases, treatments, and the effectiveness of medications in various healthcare systems.

Previous Post

Europe To Obtain 85 Million Pandemic Flu Vaccines From GSK

Next Post

With $6.26bn In Q1, The Indian Pharma Exports Grew By 8%

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post
EMA Advises Recall of AbbVie, Biogen MS Drug

With $6.26bn In Q1, The Indian Pharma Exports Grew By 8%

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In